| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 03/19/2008 | CN101146788A Improved process for preparing insecticidal (disubstitutedpropenyl) phenylalkyl substituted dihydrobenzofurans |
| 03/19/2008 | CN101146787A Agent for prevention or treatment of nocturnal behavioral disorder associated with dementia |
| 03/19/2008 | CN101146765A Tetrahydronaphthalene derivatives, method for the production and the use thereof in the form of antiphlogistics |
| 03/19/2008 | CN101143810A Allylic oxidation method for cyclohexene derivative |
| 03/19/2008 | CN101143324A Catalyst for preparing 2-methylfuran by gas-phase hydrogenation of furaldehyde and its preparation method |
| 03/19/2008 | CN100375740C Astaxanthin esters |
| 03/18/2008 | US7345181 Process for preparing prostaglandin derivatives and starting materials for the same |
| 03/18/2008 | US7345167 Method for the production of maleic anhydride |
| 03/18/2008 | US7345094 Synergistic; side effect reduction; melanomas; toxicity; 2,5-Dimethoxythiobenzoic Acid N-methylhydrazine; anticancer |
| 03/18/2008 | US7345091 Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
| 03/18/2008 | US7345068 Aromatic amino acid derivatives and medicinal compositions |
| 03/18/2008 | US7345051 For controlling mucin over-production associated with diseases such as chronic obstructive pulmonary diseases including asthma and chronic bronchitis, inflammatory lung diseases, cystic fibrosis and acute or chronic respiratory infections |
| 03/18/2008 | CA2225206C Aminophenyl ketone derivatives and a method for the preparation thereof |
| 03/18/2008 | CA2206125C N-substituted hydrazinophenylsulphonylureas, as herbicides and plant growth regulators |
| 03/13/2008 | WO2008028937A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
| 03/13/2008 | WO2008008718A3 Cyclopentane derivatives as antiglaucoma agents |
| 03/13/2008 | WO2007128899A3 Stable c-glycoside sugar and c-glycoconjugate mimetics, method for preparing same and uses thereof in particular in cosmetics and drugs |
| 03/13/2008 | US20080064886 Process for the Preparation of Optically-Active Compounds |
| 03/13/2008 | US20080064885 Process for Producing 2-Oxo-1-Phenyl-3-Oxabicyclo[3.1.0]Hexane |
| 03/13/2008 | US20080064883 Low cost, impact and chemical resistant, shaped bodies; high conversion rate and selectivity; such as maleic anhydride to tetrahydrofuran and gamma-butyrolactone |
| 03/13/2008 | US20080064874 2-Halofuryl/Thienyl-3-Carboxamides |
| 03/13/2008 | US20080064744 Reduced gastrointestinal side effects of analgesic opioid therapy |
| 03/13/2008 | US20080064733 MAGIs (membrane associated guanylate kinase proteins with inverse orientation); oncosuppressive (tumor suppressor) protein; (2-(1-Hydroxypentyl)-3-(2-phenylethyl)-6-methyl)indole-5-carboxylic acid |
| 03/13/2008 | US20080064693 N-2 Adamantanyl-2-Phenoxy-Acetamide Derivatives as 11-Beta Hydroxysteroid Dehydrogenase Inhibitors |
| 03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 03/13/2008 | US20080063849 Heat dehydration and sublimation purification of biphenyltetracarboxylic acid; purity, yield, transparency; solution polymerization with diamine; high molecular weight, heat resistance, low coloration |
| 03/13/2008 | CA2662091A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
| 03/12/2008 | EP1897541A2 Hypoglycemic agent |
| 03/12/2008 | EP1896456A2 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 03/12/2008 | EP1896439A2 Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base |
| 03/12/2008 | EP1896438A1 Phenyl-pyrazole derivatives as non-steroidal glucocorticoid receptor ligands |
| 03/12/2008 | EP1896411A2 Process for preparing renin inhibitors |
| 03/12/2008 | EP1578738B1 Escitalopram hydrobromide and a method for the preparation thereof |
| 03/12/2008 | EP1539693B1 Cannabinoid receptor agonists |
| 03/12/2008 | CN101142202A Anticancer compound, intermediate therefor, and processes for producing these |
| 03/12/2008 | CN101142201A Substituted phenyl-piperazine compounds, their preparation and use in medicaments |
| 03/12/2008 | CN101142167A Compounds that stimulate glucose utilization and methods of use |
| 03/12/2008 | CN101139333A Process for comprehensive utilization of furfural waste water |
| 03/12/2008 | CN101139332A Method for catalytic preparation of gamma-butyrolactone by using supported nano-gold catalyst |
| 03/12/2008 | CN101139331A Novel compound separated from camphor tree body and medical component |
| 03/12/2008 | CN101139330A Compound having protecting cell oxidation damaged reactivity, preparation method and uses thereof |
| 03/12/2008 | CN101139290A Method for producing vitamin C by esterification reaction-infiltration evaporation barrier separation integral process |
| 03/12/2008 | CN101139287A Method for synthesizing alkannin dimethyl ether derivative |
| 03/12/2008 | CN101139275A Halogen compound oxo reaction method |
| 03/12/2008 | CN101139267A White black falsehellebore alcohol derivative, analogue and preparation method and use thereof |
| 03/12/2008 | CN101138732A Process for preparation of cetylacetone metallic complex layered vanadium phosphorus oxygen catalyst |
| 03/12/2008 | CN100374452C Transition metal complex having diphosphine complex as ligand |
| 03/12/2008 | CN100374443C Hydrophilic polymer-thunder good vine extract binding substance and its medicinal composition |
| 03/11/2008 | US7342114 4-O esters such as thymin-1-yl alkyl ester; cancer; type II DNA topoisomerase inhibition, enzyme mediated production of lethal DNA strand breaks |
| 03/11/2008 | US7341715 Method and agents on the basis of 2-mercaptopropionic acid amides for durable hair forming and a method for producing same |
| 03/11/2008 | CA2293382C Piperazine derivatives and their use as anti-inflammatory agents |
| 03/11/2008 | CA2274954C Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient |
| 03/06/2008 | WO2008026140A2 Malodor counteracting compositions and method for their use |
| 03/06/2008 | WO2008025509A1 Benzofuran and benzothiophene derivatives useful in the treatment of cancers of the central nervous system |
| 03/06/2008 | WO2007149829A3 Therapeutic compounds |
| 03/06/2008 | WO2007146836B1 Hydroxymethylfurfural reduction methods and methods of producing furandimethanol |
| 03/06/2008 | WO2007145835A3 Benzamide derivatives as modulators of 11beta-hsd1 for treating diabetes and obesity |
| 03/06/2008 | US20080058539 in the presence of a polar solvent which is preferably added before the start of the distillation |
| 03/06/2008 | US20080058538 Process for producing fluoroalkanesulfonamide derivatives |
| 03/06/2008 | US20080058536 5-alkoxycarbonylphthtalides; suitable for large scale production and the alkoxycarbonylphtalides are obtained in high purity and in high yields |
| 03/06/2008 | US20080058389 Carboxamides |
| 03/06/2008 | US20080058383 Such as 2-methyl-2-(4-nitro-3-trifluoromethyl-phenylamino)-propan-1-ol; prostate cancer; cardiovascular disorders; psychological disorders |
| 03/06/2008 | US20080058372 2,5-bis{[alkyl(or aryl)imino]aminophenyl}furans and thiophenes; "reversed" amidines; DNA-binding affinities; microbiocide; mycobacterial, fungal, protozoal infection; Mycobacterium tuberculosis, Trypanosoma spp., Candida albicans, Aspergillus spp., Cryptosporidium parvum, Giardia lamblia, Plasmodium spp. |
| 03/06/2008 | US20080058340 MEK kinase (mitogen-activated ERK-activating kinases or MAP kinase kinase); cancer, tumors, infections, autoimmune disorders, stroke, ischemia, rheumatoid arthritis, multiple sclerosis, psoriasis, restenosis; 1-sulfonamido-2-(phenylamino)-4-fluorobenzene compounds |
| 03/06/2008 | US20080058336 Secretase inhibitor |
| 03/06/2008 | US20080058331 Inhibitors for GlyT-1 |
| 03/06/2008 | US20080058314 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/06/2008 | CA2666469A1 Benzofuran and benzothiophene derivatives useful in the treatment of cancers of the central nervous system |
| 03/05/2008 | EP1894917A1 Aryloxy- and arylthioxyacetophenone-type compounds for the treatment of cancer |
| 03/05/2008 | EP1893766A1 Chemoenzymatic process for the synthesis of escitalopram |
| 03/05/2008 | EP1893596A2 Benzoýb¨furane and benzoýb¨thiophene derivatives |
| 03/05/2008 | EP1893595A1 Preparation of (s)-4-fluoromethyl-dihydro-furan-2-one |
| 03/05/2008 | EP1893566A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia |
| 03/05/2008 | EP1411919B1 (-)-olivil as antioxidant |
| 03/05/2008 | CN101137647A Synthesis of himbacine analogs |
| 03/05/2008 | CN101137636A Exo-selective synthesis of himbacine analogs |
| 03/05/2008 | CN101137635A Method for producing alkoxylated 2,5-dihydrofuran but-2-ene derivatives or tetra-1,1,4,4-alkoxylated but-2-ene derivatives |
| 03/05/2008 | CN101134751A Method for extracting gibberellic acid GA4+7 from gibberellic acid fermentation liquor |
| 03/05/2008 | CN101134750A Process for the preparation of maleic anhydride in a microchannel reactor |
| 03/05/2008 | CN100372828C Method for producing phthalic anhydride |
| 03/05/2008 | CN100372606C Cu-B catalyst for preparing tetrahydrofuran by hydrogenation of dimethyl maleate and its preparation process |
| 03/04/2008 | US7339059 Benzofuran-2-yl-carbonyl- and indol-2-yl-carbonyl-trans-2,5-dimethyl-piperazine derivatives; rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, inflammatory bowel disease, asthma; inhibit the interaction between inflammatory chemokines and their receptor |
| 03/04/2008 | US7339014 A copolymer comprising (meth)acrylated 8 or 9-methacryloyloxy-4-oxatricyclo[5.2.1.02,6]decane-3-one monomer; chemically amplified photoresist composition comprising photoacid generator; transparency to ultraviolet light, solubility in solvents; photolithography; not from Diels-Alder reaction |
| 03/04/2008 | US7338969 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial settings like ship hulls, food processing systems, oil recovery or paper making plants |
| 02/28/2008 | WO2008024302A2 Compounds for treating proliferative disorders |
| 02/28/2008 | WO2008023823A1 Method for producing cyclic unsaturated compound |
| 02/28/2008 | WO2008023550A1 Aromatic amine derivative and organic electroluminescent device employing the same |
| 02/28/2008 | WO2008022953A1 Method for the production of d,l-2-hydroxy-4-alkylthio butyric acid |
| 02/28/2008 | WO2008022938A1 Di-aromatic substituted amides as inhibitors for glyt1 |
| 02/28/2008 | WO2008022725A1 Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral disorders |
| 02/28/2008 | WO2008022462A1 Para-quinol derivatives and methods of stereo selectively synthesizing and using same |
| 02/28/2008 | US20080051396 Costunolide derivatives |
| 02/28/2008 | US20080051374 ophthalmically acceptable for reducing intraocular pressure |
| 02/28/2008 | CA2661459A1 Di-aromatic substituted amides as inhibitors for glyt1 |
| 02/28/2008 | CA2661440A1 Compounds for treating proliferative disorders |
| 02/28/2008 | CA2661223A1 4-aminoquinazoline derivatives and methods of use thereof |
| 02/28/2008 | CA2660531A1 Compounds for treatment of proliferative disorders |
| 02/28/2008 | CA2660524A1 Compounds for treating proliferative disorders |
| 02/28/2008 | CA2660084A1 Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral diseases |
| 02/27/2008 | EP1892239A1 Inhibitors of cytosolic phospholipase A2 |